• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • Write for us
  • Contact us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • AccountLog-in/out
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

On-demand preexposure prophylaxis decreases HIV infection in high-risk men

byShayna BejaimalandShaidah Deghan, MSc. MD
December 3, 2015
in Chronic Disease, Infectious Disease
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. HIV-1 acquisition rates were significantly lower in men who used tenofovir-disoprovil fumarate (TDF) and emtricitabine (FTC) preexposure prophylaxis (PrEP).

2. TDF-FTC was associated with significantly higher rates of gastrointestinal (GI) complaints and elevated serum creatinine levels.

Evidence Rating Level: 1 (Excellent)

Study Rundown: Studies have shown potential for effective PrEP of HIV infections with antivirals such as TDF or FTC. However, these studies examined daily oral regimens, which may underestimate efficacy due to issues with daily adherence. An on-demand program of PrEP may be more efficacious as issues with adherence could be lower, especially in high-risk populations such as men who have sex with men (MSM). This double-blind randomized controlled trial examined the efficacy and safety of sexual activity-dependent PrEP with TDF-FTC in MSM.

The acquisition rates of HIV-1 were significantly decreased in men who used TDF-FTC before and after sexual activity as compared to placebo: a relative risk reduction of 86%. There were no significant differences in serious adverse events and no deaths in the study. The TDF-FTC group had higher rates of GI adverse events (nausea, vomiting, diarrhea, abdominal pain) and renal adverse events (elevations in serum creatinine). Strengths of this study include examining a novel manner of drug administration in a HIV high-risk group. Limitations include a relatively short follow-up, which does not provide information on long-term adherence.

Click to read the study, published today in NEJM

Relevant Reading: Changes in glomerular kidney function among HIV-1 uninfected men and women receiving emtricitabine-tenofovir disoproxil fumarate preexposure prophylaxis

RELATED REPORTS

The 2 Minute Medicine Podcast Episode 6

The Scan by 2 Minute Medicine®: The Genetics of Alzheimer’s Disease, the Silent Killer, a Holiday Blizzard and an HIV Vaccine on the Horizon

Risk scores perform moderately well in discriminating people living with HIV with higher vs lower cardiovascular disease risk

In-Depth [randomized controlled trial]: This double-blind, modified intention-to-treat, randomized controlled trial was conducted at six study sites in France and one in Canada from February 2012 to October 2014. Inclusion criteria were HIV-negative status men or transgendered female sex adults who have sex with men. Those with hepatitis B or C infection, chronic kidney disease or specific transaminase abnormalities were excluded. Men were randomized to either TDF-FTC or placebo. All participants received risk-reduction counselling and condoms and regularly tested for HIV and other sexually transmitted infections. The primary endpoint was the diagnosis of HIV-1 infection defined as the first evidence of HIV antibodies or p24 antigen in serum as determined by an ELISA assay.

A total of 400 participants who did not have HIV infection were enrolled: 199 in the TDF-FTC and 201 in the placebo group. The median follow-up was 9.3 months (interquartile range [IQR] 4.9 to 20.6). Participants in both the TDF-FTC and placebo group took a median of 15 pills per month (p=0.57). Of the 16 HIV-1 infections that occurred during follow-up, 2 occurred in the TDF-FTC group (incidence 0.91 per 100 person-years) and 14 in the placebo group (incidence 6.60 per 100 person-years), a relative reduction of 86% (95% [CI] 40-98%, p=0.002). There were no significant differences between groups in the frequency of serious adverse events, including zero deaths in the study period. The TDF-FTC group did have significantly higher rates of gastrointestinal events (14% vs. 5%, p=0.002) and significant increases in serum creatinine (18% vs. 10%, p=0.03).

Image: PD

©2015 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: AIDSemtricitabineHIVtenofivir
Previous Post

Lixisenatide ineffective in reducing cardiovascular events in diabetics: The ELIXA study

Next Post

Prevalence of neural tube defects unchanged over 20 years in Europe

RelatedReports

2MM Podcast

The 2 Minute Medicine Podcast Episode 6

February 9, 2023
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
The Scan by 2 Minute Medicine®

The Scan by 2 Minute Medicine®: The Genetics of Alzheimer’s Disease, the Silent Killer, a Holiday Blizzard and an HIV Vaccine on the Horizon

March 14, 2023
Few high school students, young adults get HIV testing
Cardiology

Risk scores perform moderately well in discriminating people living with HIV with higher vs lower cardiovascular disease risk

January 3, 2023
Positive physician experience in the Pediatric AIDS Corps
Cardiology

Risk of cardiovascular pathology determined using advanced cardiovascular imaging limited by heterogeneity amongst patients with human immunodeficiency virus

September 17, 2022
Next Post
Cardiovascular risk factors related to brain volume and associated dementia

Prevalence of neural tube defects unchanged over 20 years in Europe

Multidrug induction therapy increases remission from lupus nephritis

Addition of immunosuppression does not improve outcome of supportive therapy for IgA nephropathy

No benefit of erlotinib in combined hepatocellular carcinoma treatment

Radiation dose associated with increased heart disease in Hodgkin lymphoma survivors

License Our Award-Winning Physician-Written Medical News and Visual Abstracts

2 Minute Medicine is the leading authoritative medical news licensing service, and the only with reports written by practicing doctors.

LICENSE CONTENT

2MM+ Premium Access

No ads & unlimited access to all current reports, over 9000 searchable archived reports, visual abstracts, Weekly Rewinds, and the online edition of The Classics Series™ textbook.

Subscription Options
2 Minute Medicine

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Stroke may be associated with sleep disturbances in adults
  • Transcarotid artery revascularization not associated with a significant difference in 30-day risk of stroke, death and myocardial infarction compared to carotid endarterectomy
  • Drinking characteristics in adolescence predict alcohol behaviors in early adulthood
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • The Scan
  • Wellness
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

Want more physician-written
medical news?

Join over 10 million yearly readers and numerous companies. For healthcare professionals
and the public.

Subscribe for free today!

Subscription options